To include your compound in the COVID-19 Resource Center, submit it here.
Patient sample and mouse studies suggest c-MET inhibitors could help treat neurofibromatosis type II. In neural tissue from patients,
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury